Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - NOVADEL PHARMA INC | novadel10q93009.htm |
| EX-31.1 - CERTIFICATION PURSUANT TO RULE 13 (A) AND 14(A) - NOVADEL PHARMA INC | exhibit311.htm |
EXHIBIT
32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(18
U.S.C. 1350)
In
connection with the Quarterly Report of NovaDel Pharma Inc., a Delaware
corporation (the “Company”), on Form 10-Q for the three months ended September
30, 2009, as filed with the Securities and Exchange Commission (the “Report”),
I, Steven B. Ratoff, Interim President, Chief Executive Officer and Interim
Chief Financial Officer of the Company, do hereby certify, pursuant to Section
906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.§ 1350), that to my
knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
Date: November
16, 2009
|
By:
|
/s/
STEVEN B. RATOFF
|
|
Steven
B. Ratoff
|
||
|
Interim
President, Chief Executive Officer
|
||
|
and
Interim Chief Financial Officer
|
||
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
This
certification shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act, or otherwise subject to the liability of that section.
Such certification will not be deemed to be incorporated by reference into any
filing under the Securities Act or the Securities Exchange Act.